Welcome to START’s News & Information page. Here you'll find the latest news releases and articles about START. Take a moment to browse through some of the stories that have been written about START.
April 22nd, 2008
Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic
Calando Pharmaceuticals, a majority owned subsidiary of Arrowhead Research Corporation, announced today that the U.S. Food and Drug Administration (FDA) has approved its investigational new drug application (IND) for lead anti-cancer compound, CALAA-01.